The authors also demonstrated that the high-risk score correlated with more abundant Treg cells and fibroblasts, suggesting that silenced immunological response and low HHLA2 expression may be related to poor prognosis in ESCC. The gene discussed is HHLA2; the disease is esophageal squamous cell carcinoma.